Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia
Authors
Keywords
Basic fibroblast growth factor, Angiogenesis, Critical limb ischemia, Drug delivery system
Journal
HEART AND VESSELS
Volume 31, Issue 5, Pages 713-721
Publisher
Springer Nature
Online
2015-04-11
DOI
10.1007/s00380-015-0677-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia
- (2013) Mitsuyoshi Takahara et al. HEART AND VESSELS
- Transplantation of purified CD34+ cells in the treatment of critical limb ischemia
- (2013) Zhihui Dong et al. JOURNAL OF VASCULAR SURGERY
- Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia
- (2012) Makoto Kinoshita et al. ATHEROSCLEROSIS
- Safety and Effect of Adipose Tissue-Derived Stem Cell Implantation in Patients With Critical Limb Ischemia
- (2012) Han Cheol Lee et al. CIRCULATION JOURNAL
- Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease
- (2012) Ping Yang et al. HEART AND VESSELS
- Gene therapy in the treatment of peripheral arterial disease
- (2011) N. A. Mughal et al. BRITISH JOURNAL OF SURGERY
- Advances in Endovascular Treatment of Critical Limb Ischemia
- (2011) Bryan P Yan et al. CIRCULATION JOURNAL
- Autologous Bone-Marrow Mononuclear Cell Implantation Reduces Long-Term Major Amputation Risk in Patients With Critical Limb Ischemia
- (2011) Naomi Idei et al. Circulation-Cardiovascular Interventions
- Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia
- (2011) Michael P. Murphy et al. JOURNAL OF VASCULAR SURGERY
- Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
- (2011) Jill Belch et al. LANCET
- Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia
- (2010) H Shigematsu et al. GENE THERAPY
- Autologous stem cell therapy for peripheral arterial disease
- (2009) Gian Paolo Fadini et al. ATHEROSCLEROSIS
- Interventional Management of Critical Limb Ischemia in Renal Patients
- (2008) Ivan P. Casserly ADVANCES IN CHRONIC KIDNEY DISEASE
- Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia
- (2008) Satoaki Matoba et al. AMERICAN HEART JOURNAL
- Results of a Double-Blind, Placebo-Controlled Study to Assess the Safety of Intramuscular Injection of Hepatocyte Growth Factor Plasmid to Improve Limb Perfusion in Patients With Critical Limb Ischemia
- (2008) Richard J. Powell et al. CIRCULATION
- Sustained Release of Prostaglandin E1 Potentiates the Impaired Therapeutic Angiogenesis by Basic Fibroblast Growth Factor in Diabetic Murine Hindlimb Ischemia
- (2008) Yuhong Huang et al. CIRCULATION JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More